A share price of Apogee Therapeutics Inc [APGE] is currently trading at $49.21, down -0.73%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The APGE shares have gain 8.63% over the last week, with a monthly amount drifted -1.52%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Apogee Therapeutics Inc [NASDAQ: APGE] stock has seen the most recent analyst activity on November 25, 2024, when Canaccord Genuity initiated its Buy rating and assigned the stock a price target of $89. Previously, BofA Securities started tracking the stock with Buy rating on May 10, 2024, and set its price target to $80. On December 20, 2023, BTIG Research initiated with a Buy rating and assigned a price target of $43 on the stock. Wedbush started tracking the stock assigning a Outperform rating and suggested a price target of $40 on August 08, 2023. TD Cowen initiated its recommendation with a Outperform. Stifel started tracking with a Buy rating for this stock on August 08, 2023, and assigned it a price target of $34. In a note dated August 08, 2023, Jefferies initiated an Buy rating and provided a target price of $29 on this stock.
Apogee Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $27.05 and $72.29. Currently, Wall Street analysts expect the stock to reach $95 within the next 12 months. Apogee Therapeutics Inc [NASDAQ: APGE] shares were valued at $49.21 at the most recent close of the market. An investor can expect a potential return of 93.05% based on the average APGE price forecast.
Analyzing the APGE fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.19, Equity is -0.22 and Total Capital is -0.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 48.15 points at the first support level, and at 47.09 for the second support level. However, for the 1st resistance point, the stock is sitting at 49.92, and for the 2nd resistance point, it is at 50.63.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Apogee Therapeutics Inc [NASDAQ:APGE] is 16.39. In addition, the Quick Ratio stands at 16.39 and the Cash Ratio stands at 3.64.
Transactions by insiders
Recent insider trading involved HENDERSON MICHAEL THOMAS, Officer, that happened on Jan 08 ’25 when 15000.0 shares were purchased. Chief Medical Officer, Dambkowski Carl completed a deal on Jan 02 ’25 to sell 4085.0 shares. Meanwhile, Director McKenna Mark C. bought 20000.0 shares on Dec 12 ’24.
